(19)
(11) EP 3 897 570 A1

(12)

(43) Date of publication:
27.10.2021 Bulletin 2021/43

(21) Application number: 19829134.6

(22) Date of filing: 18.12.2019
(51) International Patent Classification (IPC): 
A61K 9/00(2006.01)
A61K 38/26(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/0019; A61K 38/26
(86) International application number:
PCT/EP2019/085942
(87) International publication number:
WO 2020/127476 (25.06.2020 Gazette 2020/26)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 19.12.2018 SI 201800275
12.09.2019 SI 201900172

(71) Applicant: KRKA, d.d., Novo mesto
8501 Novo mesto (SI)

(72) Inventors:
  • ROZMAN, Sasa
    8270 Krsko (SI)
  • KOLESA DOBRAVC, Tanja
    8311 Kostanjevica na Krki (SI)
  • SLADIC, Gordan
    8000 Novo Mesto (SI)
  • VIDIC, Iztok
    1000 Ljubljana (SI)
  • LIN, Haowen
    Shenzhen Hi-tech Industrial Park 518057 Guangdong (CN)
  • HE, Guotao
    Shenzhen Hi-tech Industrial Park 518057 Guangdong (CN)
  • QIN, Liangzheng
    Shenzhen Hi-tech Industrial Park 518057 Guangdong (CN)

(74) Representative: Hoffmann Eitle 
Patent- und Rechtsanwälte PartmbB Arabellastraße 30
81925 München
81925 München (DE)

   


(54) PHARMACEUTICAL COMPOSITION COMPRISING GLP-1 ANALOGUE